Wall Street analysts expect Cytokinetics, Inc. (NASDAQ:CYTK) to post $8.45 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Cytokinetics’ earnings, with the highest sales estimate coming in at $9.39 million and the lowest estimate coming in at $7.50 million. Cytokinetics reported sales of $10.64 […]
